Pre-approval Access Single Patient Request for Teclistamab (JNJ-64007957)
Teclistamab pre-approval access in relapsed or refractory multiple myeloma.
Multiple Myeloma
DRUG: Teclistamab
Teclistamab pre-approval access in relapsed or refractory multiple myeloma.